Inhibitors of the Interactions between HIV-1 IN and the Cofactor LEDGF/p75
✍ Scribed by Dr. Laura De Luca; Dr. Stefania Ferro; Dr. Francesca Morreale; Dr. Sara De Grazia; Prof. Alba Chimirri
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 471 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1860-7179
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract An optimised method of solution cyclisation gave us access to a series of peptides including SLKIDNLD (**2**). We investigated the crystallographic complexes of the HIV integrase (HIV‐IN) catalytic core domain with 13 of the peptides and identified multiple interactions at the binding s
The interaction between HIV-1 protease and reversible inhibitors was studied by surface plasmon resonance biosensor technology. The steady-state binding level and the time course of association and dissociation could be observed by measuring the binding of inhibitors injected in a continuous flow of
## Abstract Peptides are valuable tools for studying protein–protein interactions, especially in cases of isolated protein domains and natively unfolded proteins. Here, we used peptides to quantitatively characterize the interaction between the natively unfolded HIV‐1 Tat protein and the tetrameriz
does not contain a basic amine as do Saquinovir and JG-365, for example it should be easier to desolvate, which also assists in binding. The relationship between KNI-272, JG-365, Saquinovir, and P X proline-containing substrate also is 1